RAD — Radiopharm Theranostics Balance Sheet
0.000.00%
- AU$48.41m
- AU$10.78m
- AU$0.30m
- 17
- 22
- 52
- 22
Annual balance sheet for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.027 | 27 | 11.7 | 18.6 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.006 | 0.056 | 4.47 | 0.987 |
Total Other Current Assets | ||||
Total Current Assets | 0.033 | 27.3 | 16.3 | 22.8 |
Net Property, Plant And Equipment | — | 0.002 | 0.068 | 0.061 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 0.033 | 83.4 | 74.9 | 72 |
Accounts Payable | ||||
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.158 | 7.88 | 13.2 | 17.6 |
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.158 | 20.4 | 30.6 | 43.9 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.125 | 63 | 44.4 | 28.1 |
Total Liabilities & Shareholders' Equity | 0.033 | 83.4 | 74.9 | 72 |
Total Common Shares Outstanding |